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Summary 
Type II collagen-induced arthritis (CIA) is an experimentally inducible autoimmune disorder 
that is, just like several forms of human arthritis, influenced by a genetic background. Immunization 
of young rhesus monkeys (Macaca mulatta) with type II collagen (CII) induced CIA in about 
70%  of the animals. One major histocompatibility complex (MHC) class I allele was present 
only in young animals resistant to CIA and absent in arthritic animals. This strong association 
suggests that the MHC class I allele itself, or a closely linked gene, determines resistance to 
CIA. The mechanism controlling the resistance to CIA becomes less efficient in aged animals 
since older rhesus monkeys, which were positive for the resistance marker, developed a mild form 
of arthritis. At the cellular level it is demonstrated that resistance to CIA is reflected by a low 
responsiveness of T  cells to CII.  This association between a specified MHC class I allele and 
resistance to an autoimmune disease points at the importance of the MHC class I region in the 
regulation of the immune response to an autoantigen. 
T 
he highly polymorphic MHC region, which is known 
in humans as the human leukocyte antigen (HLA) system, 
plays a pivotal role in controlling the immune response to 
foreign pathogens.  The MHC class I and II glycoproteins 
bind peptides derived from intracellular enzymatic degrada- 
tion of proteins and subsequently present them on the cell 
surface to CD8 + CTL and CD4 § (primarily helper) T cells, 
respectively (1, 2). MHC class I and II region-encoded sus- 
ceptibility genes for several autoimmune diseases have been 
documented in humans  and experimental animals models 
(3-7). MHC genes associated with resistance to autoimmune 
disorders are relatively rare and have until now only been 
mapped to the class II region (8,  9). 
Collagen-induced arthritis (CIA) 1 is an experimental an- 
imal model for studying immunoregulatory mechanisms un- 
derlying an autoimmune disease. Upon intradermal immu- 
nization  with  type II  collagen (CII),  the major cartilage 
protein, rhesus monkeys as well as rodents develop CIA that 
shares  several pathologic features with human rheumatoid 
arthritis (RA) (10,  11). Human RA is associated  with the 
t Abbreviations  used in this~la'r: AS, ankylosing spondylitis; CIA, collagen- 
induced arthritis; CII, type II collagen; RA, rheumatoid arthritis. 
HLA-DR1 and -Dlk4 serotypes (12, 13), while in mice sus- 
ceptibility to CIA has been mapped to a critical site of an 
I-A allele encoded by the MHC class II region (14). 
In this study the genetic influence of MHC genes on the 
development of CIA in rhesus monkeys was investigated.  The 
current knowledge of the MHC of the rhesus monkey, re- 
cently named MhcMamu (15), located on chromosome 2, is 
primarily based on serological data. Allo-antisera allow the 
detection of 13 Mamu-A and 14 Mamu-B locus products while 
more than 10 allelic specificities are encoded by the Mamu- 
DR locus (16,  17).  Recently, the knowledge of the MHC 
systems in different nonhuman primate species has expanded 
rapidly. These studies demonstrate that MHC polymorphisms 
are inherited in a trans-spedes mode of evolution (18,  19) 
which means that the evolution of MHC alleles does not start 
at the inception of a species, but is rather a process in which 
a major group of alleles is passed on in the phylogeny from 
one species to another. The major implication of this finding 
is that some alleles of different species are more related to 
each other than the MHC alleles within a species. This type 
of relationship may have functional implications as is reflected 
by antigen presentation studies across a species barrier (20). 
Therefore,  the identification of MHC  genes or  alleles  as 
markers for susceptibility or resistance to autoimmune dis- 
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derstanding the pathogenesis and immunoregulation of human 
autoimmune diseases. 
Materials and Methods 
Animals.  Most rhesus monkeys (Macaca raulatta) used in this 
study were born and raised at the ITKI-TNO  Primate Center. 
Monkeys that were born outside the Primate Center are BB25 and 
BB37, born in the Zoo Beekse  Bergen (Amhem, The Netherlands); 
3974 and 3982, born in Bethesda Primate Center (Bethesda, MD), 
and monkeys 2822, 2774, and 3215 were imported from India at 
a young age. Monkeys  4062, 4070, 4116, and 4106 were imported 
from Burma at a young age. All monkeys  were typed for MhcMamu 
antigens using standard serological techniques (16). The animals 
used in the experiments were randomly sdected from the colony. 
The sex and age of the animals are given in Table 1. The animals 
were examined,  weighed, and bled under ketamine  anesthesia. When 
an animal suffered  from pain, 0.06 mg Buprenorfme  was given twice 
daily by intramuscular injection  (Temgesic, Warrick BV,  The 
Netherlands). The experiments have been approved by the TNO 
ethical committee for animal experiments. Throughout the experi- 
ments the animals were under veterinary surveillance. 
Collagens.  Native  bovine type II collagen (B-CII), isohted from 
bovine articular cartilage, was a kind gift from Dr. J. van Kampen, 
Dr. Jan van Breemen Institute (Amsterdam, The Netherlands). The 
isolation of B-CII and rhesus monkey CII (Rh-CII), respectively, 
from the bovine and rhesus monkey nasal septa has been described 
elsewhere (10). 
Arthritis Induction.  The  animals were immunized by intra- 
cutaneous injection on the back with 1 ml of an emulsion (1:1) 
of  purified B-CII or Rh-CII dissolved  in 0.1 M acetic  acid and CFA 
(Difco Laboratories, Detroit,  MI). CII doses in the primary im- 
munizations are given in Table 1. The disease  severity  was quantified 
in an arthritic score as explained in the legend to Table 1. 
Proliferation of Mononuclear Cells.  PBMC were isolated from 
heparinized blood by density gradient centrifugation (LSM; Or- 
ganon Technika, Durham, NC). The cells from the interphase of 
the gradient were washed twice with HBSS (Gibco Ltd., Paisley, 
Scotland) and resuspended  in culture medium, consisting of Hepes- 
buffered RPMI 1640 (Gibco Ltd.) supplemented with L-glutamine 
(200 mM; Gibco Ltd.), 0.15% NaHCO3, 200 U/ml penicillin, 
200 U/nil streptomycin  (both Gibco Ltd.), and 20% heat-inactivated 
pooled nonimmune rhesus monkey serum. PBMC were cultured 
for 6 d in 96-well round-bottomed plates (Greiner, Labortechnik, 
Germany) in  a humidified atmosphere containing  5%  CO2 at 
37~  at a concentration of 5  x  104 cells per well. Denatured CII 
was added in the optimal concentration of 50 #g/ml. Cell prolifer- 
ation was measured by the incorporation of [3H]thymidine (0.5 
#Ci per well) during the final 8 h of the culture. 
Results and Discussion 
After immunization of 24  MHC-typed young animals 
(<6.5 yr of age) with heterologous or homologous CII, 16 
young animals developed CIA (Table 1). No apparent associ- 
ation was observed between susceptibility, sex, and immuni- 
zation dose of CII or between Mamu-DR and CIA. How- 
ever,  seven  of  eight  resistant  animals  shared  the  same 
serologically defined MHC class I allele (Mamu-A26), which 
was absent in all 18 young animals that developed  CIA (p 
<  0.00002).  Only one of the resistant animals (8675) lacks 
the Mamu-A26 allele (Table 1). To our knowledge this is the 
first demonstration that resistance to an autoimmune disease, 
which can be evoked by immunization with a soluble an- 
tigen, is associated with the MHC class I region. So far, re- 
sistance markers for autoimmune diseases have been exclu- 
sively  linked  to  the  MHC  class  II  region  (8,  9).  The 
Mamu-A26-associated resistance seems unique for CIA since 
this phenomenon was not observed  in rhesus monkeys im- 
munized with myelin basic protein to evoke experimental au- 
toimmune encephalomyelitis (data not shown). Because in 
both models immunization was performed with CFA, it is 
unlikely that the Mamu-A26-associated resistance is due to 
the adjuvant. 
It is generally accepted that during aging the capacity of 
the immune system to maintain tolerance to autoantigens 
decreases. To study whether the association between Mamu- 
A26 and resistance  to CIA holds true in old animals,  one 
male and four female monkeys of >22 yr of age were im- 
munized with CII. The Mamu-A26-positive old animals (3215 
and 2822) developed arthritis, but the severity of the disease 
was  clearly less than  in  the  Mamu-A26-negative animals 
(Table 1). 
Using biochemical methods the MHC class I gene prod- 
ucts were characterized in more detail. One-dimensional IEF 
of class I products, immunoprecipitated by using the anti- 
MHC class I mAb W6/32, demonstrated that the Mamu-A 
and -B serotypes correlate with isoelectric  point differences 
(manuscript in preparation). In addition, such experiments 
also showed that all Mamu-A26-positive animals share one 
product with a similar isoelectric  point that was absent in 
the Mamu-A26-negative animals. 
There appears  to exist a strong correlation between the 
Mamu-A26 allele and resistance to develop CIA. The ques- 
tion arises, whether Mamu-A26 itself confers resistance,  or 
whether it functions as a marker for a closely linked regu- 
lator gene. At present it is not known whether the Mamu-A 
alleles are equivalent to the HLA-A or -B alleles. Therefore, 
we can not exclude that other genes, like some of the HLA- 
B-associated  transcripts (BAT), exhibit polymorphism and 
may be linked to Mamu-A26 (21-23).  In this respect,  it is 
of interest that some BAT genes encode for coUagen-like struc- 
tures (24).  A potential problem with any association  study 
is population stratification. In this case, the A26 allele may 
mark a subset of rhesus monkeys resistant to CIA because 
of other genes in that subset. In this respect, we are studying 
Va usage in TCR diversity in order to elucidate whether 
other polymorphic gene systems may play a role in resistance 
to CIA. The alternative option is that the Mamu-A26 allele 
determines resistance by itself. MHC class I molecules present 
peptides from intraceUular origin to CTL (1), whereas soluble 
antigens derived from extracellular pathogens  are  usually 
presented by MHC class II molecules (2). When the Mamu- 
A26 allele itself is involved in resistance to CIA, the question 
has to be answered if Mamu-A26 molecules are able to bind 
self-peptides  from CII, which is a soluble antigen. This is 
not unlikely because it has been documented recently that 
peptides derived from soluble proteins can complex with class 
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MhcMamu* 
Immunization  Anti-CII 
Animals  Rhesus monkey  Sex  Age*  A  B  DR  dose  s  T  cell response  Arthritis  I 
yr  mg 
Young  BB25  cr  6.0  -,-  10,-  3,8  1.5  +  +  +  + 
2BN  cr  3.5  11,18  9,19  3,4  1.5  +  +  +  + 
BB37  9  3.0  -,31  -,-  3,2  1.5  +  +  +  + 
1WF  9  4.0  11,32  9,28  2,5  1.5  +  +  +  + 
1JT  Q  6.5  11,24  19,33  3,2  1.5  +  +  +  + 
1KM  9  6.0  11,14  1,19  3,1  3.0  +  +  + 
D3  cr  4.0  17,18  3,28  1,1  1.5  +  +  + 
M15  cr  4.0  11,2  6,21  3,8  3.0  +  +  + 
1OX  Q  5.0  11,13  9,9  -,8  3.0  +  +  + 
L65  9  5.0  -,2  -,-  2,8  1.5  +  +  + 
4062  cr  6.0  11,20  10,-  2,3  1.0  +  +  + 
4116  cr  7.0  18,29  33,-  2,4  1.0  +  +  + 
4070  cr  8.0  2,31  6,-  2,-  1.0  +  + 
8827  cr  1.5  2,11  10,27  1,2  1.0  +  + (s) 
8765  Q  3.0  17,32  10,27  101,8  1.0(r)  +  + (s) 
8684  Q  4.0  2,17  10,22  8,1  1.0(r)  -  + (s) 
8675  O"  3.0  2,11  6,10  1,3  1.0  -  - 
M14  O"  4.0  11,26  6,19  2,8  3.0  -  - 
1UY  cr  3.5  11,26  19,27  1,2  3.0  -  - 
1RO  Q  4.5  24,26  6,-  3,3  1.0  -  - 
1NR  cr  5.5  11,26  21,23  5,101  1.0  -  - 
8769  Cr  2.0  11,26  27,19  1,2  1.0  +  - 
8781  9  3.0  2,26  19,23  3,3  1.0(r)  -  - 
4106  Q  6.0  -,26  6,-  8,5  1.0(r)  -  - 
Old  2774  cr  >23  11,32  10,19  3,101  1.0  +  +  + 
3974  9  >23  2,13  6,10  4,1  1.0  +  +  +  + 
3982  Q  >22  14,32  6,23  4,5  1.0  +  +  +  + 
3215  Q  >23  13,26  9,6  5,3  1.0  +  + (s) 
2822  Q  >22  31,26  33,6  1,3  1.0  +  + 
" MhcMarau-A. -B, and -DR locus alleles have been identified serologically (16).  The A26 allele has been printed in bold. 
* Age at time of immunization. In captivity  rhesus monkeys can reach a maximum of 30-35 yr of age. 
S All rhesus monkeys are immunized with B-CII. (r) Animals immunized with Rh-CII. 
II The CIl-dependent T cell proliferation  is scored as negative ( -  ) if the stimulation indices (cpm from cells cultured with Cll/cpm from cells cul- 
tured only in culture medium) was <2 during the first 25 wk after the primary immunization with CII. A positive score (+) is given when the 
stimulation indices are >2. The anti-CII T  cell response in the responding  animals ranged from 4,000  to 23,000 cpm,  whereas the nonresponder 
al'rimal reached levels of 300 cpm, which is approximately  equal to the controls,  done with medium with no antigen. 
The arthritic  score is as follows:  + + +, severe soft tissue swelling of all small joints of hands and feet and of the wrists and ankle joints;  + +, 
moderate  soft tissue swelling of most small joints of hands and feets and wrists  and ankle joints;  +, moderate  soft tissue swelling only of wrists 
and ankle joints;  + (s), sub-clinical arthritis  only manifest by elevated erythrocyte  sedimentation rate and C-reactive protein levels and the detection 
of anti-CII T  cell response and IgM antibodies  (30). 
I molecules (25). As shown in Table 1, resistance to CIA in 
rhesus monkeys is accompanied by in vitro CII-specific T  cell 
low  responsiveness.  The binding of peptides  from  CII by 
Mamu-A26 molecules and subsequent presentation to regu- 
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lator CD8-positive T  cells, which can eliminate APC such 
as CII-reactive B  cells and cells of the macrophage lineage 
(26), may be an effective mechanism in the prevention of CIA. 
After repeated immunizations with CII, all arthritic monkeys acquire resistance to the disease,  which is also reflected by 
a T  cell low responsiveness to CII. Therefore, it is possible 
that other class I alleles,  although less efficiently than A26, 
mediate resistance to CIA  in  a similar  manner. 
Findings in the human population on associations between 
certain HLA class I alleles and protection to disease are mainly 
observed for infectious diseases (27, 28). On the other hand, 
there exists a strong counterpart of the MHC class I-linked 
resistance to CIA in nonhuman primates, namely the associ- 
ation between HLA-B27 and ankylosing spondylitis (AS) (3, 
4), which is an inflammatory disease predominantly affecting 
the joints of the spine and the pelvis. Although MHC class 
I  determines  in AS susceptibility and in CIA  resistance  to 
disease, both associations are remarkably strong. At present 
it is disputed whether AS is an autoimmune or an infectious 
disease (29). Apart from that, the antigen that causes AS has 
not been identified.  However, in the case of CIA, disease is 
evoked by a known autoantigen, namely CII. Therefore, this 
arthritis model is most suitable to investigate  the role of MHC 
class  I  genes in the immunoregulation  of autoimmune  ar- 
thritis  in primates. 
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